The cytotoxicity of all compounds was tested in an in vitro triple coculture model system for ABCB1-mediated MDR in uterine sarcoma lines, and a subset was probed against a triple-negative, BRCA1-deficient murine breast cancer line and its cisplatin-resistant derivative. This evidence concerns the gene ABCB1 and uterine corpus sarcoma.